(Q37894294)

24 August 2017

1 reference

title

Serological diagnostics of hepatitis E virus infection (English)

1 reference

24 August 2017

0 references

1 reference

hepatitis E virus

1 reference

Yury Khudyakov

1

1 reference

PubMed ID

21704091

24 August 2017

Saleem Kamili

series ordinal

2

1 reference

24 August 2017

15 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

161

1 reference

24 August 2017

1

1 reference

24 August 2017

84-92

1 reference

Experimental studies on subclinical hepatitis E virus infection in cynomolgus macaques

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Epidemiology of hepatitis E: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Molecular virology of hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

ELISA for IgG-class antibody to hepatitis E virus based on a highly conserved, conformational epitope expressed in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

The natural autoantibodies system: between hypotheses and facts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Prevalence of Hepatitis E virus-specific antibodies in sera of German domestic pigs estimated by using different assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin m antibodies to hepatitis e virus in human sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Viremia, Fecal Shedding, and IgM and IgG Responses in Patients with Hepatitis E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Autochthonous hepatitis E in southwest England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Diagnosis of acute hepatitis E by antibody and molecular testing: a study on 277 suspected cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Serologic identification of hepatitis E virus infections in epidemic and endemic settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Prevalence of hepatitis E virus infection in Japanese children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Double-antigen enzyme-linked immunosorbent assay for detection of hepatitis E virus-specific antibodies in human or swine sera.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Profile of acute infectious markers in sporadic hepatitis E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Evidence of hepatitis E virus exposure among seronegative healthy residents of an endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Indigenous hepatitis E virus infection in England: more common than it seems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Human linear B-cell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependent RNA polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Epitope mapping in proteins of hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Immunodominant antigenic regions in a structural protein of the hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Comparative characterization of antigenic epitopes in the immunodominant region of the protein encoded by open reading frame 3 in Burmese and Mexican strains of hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Hepatitis E and long-term antibody status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Spectrum of hepatitis E virus infection in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Pathogenetic elements of hepatitis E and animal models of HEV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Expression and characterization of the hepatitis E virus ORF3 protein in the methylotrophic yeast, Pichia pastoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Recombinant subunit ORF2.1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

A single amino acid substitution changes antigenicity of ORF2-encoded proteins of hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E Virus Antibody Serum Panel Evaluation Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Active surveillance for acute viral hepatitis in rural villages in the Nile Delta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Identification and characterization of the neutralization epitope(s) of the hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Hepatitis E virus: animal reservoirs and zoonotic risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Hepatitis E virus infection in developed countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Evaluation of diagnostic assays for hepatitis E virus in outbreak settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Hepatitis E antibody kinetics in Nepalese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii: use for diagnosis of acute acquired toxoplasmosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Viraemia and faecal shedding of HEV in symptom-free carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

A new enzyme immunoassay for the detection of antibody to hepatitis E virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Application of truncated immunodominant polypeptide from hepatitis E virus (HEV) ORF2 in an assay to exclude nonspecific binding in detecting anti-HEV immunoglobulin M

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Viral specificity of hepatitis E virus antigens identified by fluorescent antibody assay using recombinant HEV proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

The molecular epidemiology of hepatitis E virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Synthesis and application of hepatitis E virus peptides to diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Prior infection of pigs with a genotype 3 swine hepatitis E virus (HEV) protects against subsequent challenges with homologous and heterologous genotypes 3 and 4 human HEV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Correlation between positivity for immunoglobulin A antibodies and viraemia of swine hepatitis E virus observed among farm pigs in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Hepatitis E indigenous to economically developed countries: to what extent a zoonosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Hepatitis E epidemic, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Molecular and serological characterization of sporadic acute hepatitis E in a Japanese patient infected with a genotype III hepatitis E virus in 1993.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

A new artificial antigen of the hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Hepatitis: Hepatitis E vaccination--is HEV 239 the breakthrough?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Spatial configuration of hepatitis E virus antigenic domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Characterization of antigenic epitopes of the ORF2 protein from hepatitis E virus genotype 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Occurrence of hepatitis E virus IgM, low avidity IgG serum antibodies, and viremia in sporadic cases of non-A, -B, and -C acute hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Relationships among viral diagnostic markers and markers of liver function in acute hepatitis E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Screening of specific diagnostic peptides of swine hepatitis E virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Sensitivity and specificity of viral immunoglobulin M determination by indirect enzyme-linked immunosorbent assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

7 January 2021

Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

7 January 2021

Hepatitis E virus: identification of type-common epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

7 January 2021

Expression in animal cells and characterization of the hepatitis E virus structural proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.06.006

7 January 2021

10.1016/J.VIRUSRES.2011.06.006

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21704091